Compare $LTRN vs $ZEOX | Chartloom

Compare

$LTRN vs $ZEOX

Lantern Pharma Inc · ZEO ScientifiX Inc

LTRN

Lantern Pharma Inc

ZEOX

ZEO ScientifiX Inc

Compare $LTRN vs $ZEOX

Comparing Lantern Pharma Inc and ZEO ScientifiX Inc

LTRNLantern Pharma Inc

ZEOXZEO ScientifiX Inc

LTRNLantern Pharma Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-73.9%

52W performance

-82.3%

FCF yield

-135.8%

ZEOXZEO ScientifiX Inc

Market cap

$9M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

52.8%

YTD performance

-55.7%

52W performance

-16.5%

FCF yield

-14.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LTRN

ZEOX

Detailed metrics comparison

LTRN

Lantern Pharma Inc

ZEOX

ZEO ScientifiX Inc

Market Cap

LTRN$10M

ZEOX$9M

Enterprise Value

LTRN$4M

ZEOX$8M

Price

LTRN$0.81

ZEOX$1.19

P/E Ratio

LTRNN/A

ZEOXN/A

P/S Ratio

LTRN0.00x

ZEOX1.33x

EV/Sales

LTRN0.00x

ZEOX1.11x

EV/EBITDA

LTRN0.00x

ZEOX0.00x

P/B Ratio

LTRN3.19x

ZEOX16.07x

P/FCF Ratio

LTRNN/A

ZEOXN/A

EV/FCF

LTRN-0.26x

ZEOX-5.77x

PEG Ratio

LTRNN/A

ZEOXN/A

Forward P/E (NTM)

LTRNN/A

ZEOXN/A

Forward P/S (NTM)

LTRNN/A

ZEOXN/A

Revenue (TTM)

LTRN$0

ZEOX$7M

Revenue Growth (YoY)

LTRNN/A

ZEOX52.8%

Forward Rev Growth

LTRN0.0%

ZEOX0.0%

Gross Margin (TTM)

LTRN0.0%

ZEOX81.5%

Operating Margin (TTM)

LTRN0.0%

ZEOX0.0%

EBITDA Margin (TTM)

LTRN0.0%

ZEOX-58.0%

Net Margin (TTM)

LTRN0.0%

ZEOX-55.6%

FCF Margin (TTM)

LTRNN/A

ZEOX-19.3%

Net Income (TTM)

LTRN$-19M

ZEOX$-4M

FCF (TTM)

LTRN$-14M

ZEOX$-1M

EPS (TTM)

LTRN-$1.50

ZEOX-$0.50

ROE (TTM)

LTRN-19835.0%

ZEOX0.0%

ROA (TTM)

LTRN-18428.0%

ZEOX-16123.0%

ROIC (TTM)

LTRN-19835.0%

ZEOX0.0%

Cash

LTRN$7M

ZEOX$2M

Debt

LTRN$0

ZEOX$343K

Net Cash/Debt

LTRN$7M

ZEOX$2M

Current Ratio (TTM)

LTRN1.96x

ZEOX1.05x

Quick Ratio (TTM)

LTRN1.70x

ZEOX0.68x

Debt/Equity (TTM)

LTRN0.00x

ZEOX0.48x

Debt/Assets (TTM)

LTRN0.0%

ZEOX0.0%

Interest Coverage (TTM)

LTRNN/A

ZEOXN/A

Net Debt/EBITDA (TTM)

LTRN0.00x

ZEOX0.00x

Beta

LTRN2.42

ZEOX1.94

52W Performance

LTRN-82.3%

ZEOX-16.5%

YTD Performance

LTRN-73.9%

ZEOX-55.7%

% from 52W High

LTRN-82.7%

ZEOX-60.4%

% from 52W Low

LTRN6.9%

ZEOX22.2%

Asset Turnover (TTM)

LTRN0.00x

ZEOX2.90x

FCF Yield (TTM)

LTRN-135.8%

ZEOX-14.5%

Earnings Yield (TTM)

LTRN-179.9%

ZEOX-41.8%

Dividend Yield (TTM)

LTRNN/A

ZEOXN/A

Rule of 40

LTRN0.0

ZEOX33.4

EV/GP/RG

LTRNN/A

ZEOXN/A

Ticker research

View LTRN research View ZEOX research

Metric	LTRN Lantern Pharma Inc	ZEOX ZEO ScientifiX Inc
Market & Valuation
Market Cap	$10M	$9M
Enterprise Value	$4M	$8M
Price	$0.81	$1.19
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.33x
EV/Sales	0.00x	1.11x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.19x	16.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.26x	-5.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$7M
Revenue Growth (YoY)	N/A	52.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	81.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-58.0%
Net Margin (TTM)	0.0%	-55.6%
FCF Margin (TTM)	N/A	-19.3%
Net Income (TTM)	$-19M	$-4M
FCF (TTM)	$-14M	$-1M
EPS (TTM)	-$1.50	-$0.50
ROE (TTM)	-19835.0%	0.0%
ROA (TTM)	-18428.0%	-16123.0%
ROIC (TTM)	-19835.0%	0.0%
Financial Health
Cash	$7M	$2M
Debt	$0	$343K
Net Cash/Debt	$7M	$2M
Current Ratio (TTM)	1.96x	1.05x
Quick Ratio (TTM)	1.70x	0.68x
Debt/Equity (TTM)	0.00x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	1.94
52W Performance	-82.3%	-16.5%
YTD Performance	-73.9%	-55.7%
% from 52W High	-82.7%	-60.4%
% from 52W Low	6.9%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	2.90x
FCF Yield (TTM)	-135.8%	-14.5%
Earnings Yield (TTM)	-179.9%	-41.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	33.4
EV/GP/RG	N/A	N/A
Ticker research	View LTRN research	View ZEOX research

Valuation

P/S Ratio

LTRN

0.00x

ZEOX

1.33x

EV/FCF

ZEOX

-5.77x

LTRN

-0.26x

Growth & revenue

Revenue Growth TTM

ZEOX

52.8%

Forward Revenue Growth

LTRN

0.0%

ZEOX

0.0%

Profitability & performance

Gross Margin

ZEOX

81.5%

LTRN

0.0%

ROE

ZEOX

0.0%

LTRN

-19835.0%

FCF Yield %

ZEOX

-14.5%

LTRN

-135.8%

52-Week Performance

ZEOX

-16.5%

LTRN

-82.3%

Detailed metrics comparison

LTRN

Lantern Pharma Inc

ZEOX

ZEO ScientifiX Inc

Market Cap

LTRN$10M

ZEOX$9M

Enterprise Value

LTRN$4M

ZEOX$8M

Price

LTRN$0.81

ZEOX$1.19

P/E Ratio

LTRNN/A

ZEOXN/A

P/S Ratio

LTRN0.00x

ZEOX1.33x

EV/Sales

LTRN0.00x

ZEOX1.11x

EV/EBITDA

LTRN0.00x

ZEOX0.00x

P/B Ratio

LTRN3.19x

ZEOX16.07x

P/FCF Ratio

LTRNN/A

ZEOXN/A

EV/FCF

LTRN-0.26x

ZEOX-5.77x

PEG Ratio

LTRNN/A

ZEOXN/A

Forward P/E (NTM)

LTRNN/A

ZEOXN/A

Forward P/S (NTM)

LTRNN/A

ZEOXN/A

Revenue (TTM)

LTRN$0

ZEOX$7M

Revenue Growth (YoY)

LTRNN/A

ZEOX52.8%

Forward Rev Growth

LTRN0.0%

ZEOX0.0%

Gross Margin (TTM)

LTRN0.0%

ZEOX81.5%

Operating Margin (TTM)

LTRN0.0%

ZEOX0.0%

EBITDA Margin (TTM)

LTRN0.0%

ZEOX-58.0%

Net Margin (TTM)

LTRN0.0%

ZEOX-55.6%

FCF Margin (TTM)

LTRNN/A

ZEOX-19.3%

Net Income (TTM)

LTRN$-19M

ZEOX$-4M

FCF (TTM)

LTRN$-14M

ZEOX$-1M

EPS (TTM)

LTRN-$1.50

ZEOX-$0.50

ROE (TTM)

LTRN-19835.0%

ZEOX0.0%

ROA (TTM)

LTRN-18428.0%

ZEOX-16123.0%

ROIC (TTM)

LTRN-19835.0%

ZEOX0.0%

Cash

LTRN$7M

ZEOX$2M

Debt

LTRN$0

ZEOX$343K

Net Cash/Debt

LTRN$7M

ZEOX$2M

Current Ratio (TTM)

LTRN1.96x

ZEOX1.05x

Quick Ratio (TTM)

LTRN1.70x

ZEOX0.68x

Debt/Equity (TTM)

LTRN0.00x

ZEOX0.48x

Debt/Assets (TTM)

LTRN0.0%

ZEOX0.0%

Interest Coverage (TTM)

LTRNN/A

ZEOXN/A

Net Debt/EBITDA (TTM)

LTRN0.00x

ZEOX0.00x

Beta

LTRN2.42

ZEOX1.94

52W Performance

LTRN-82.3%

ZEOX-16.5%

YTD Performance

LTRN-73.9%

ZEOX-55.7%

% from 52W High

LTRN-82.7%

ZEOX-60.4%

% from 52W Low

LTRN6.9%

ZEOX22.2%

Asset Turnover (TTM)

LTRN0.00x

ZEOX2.90x

FCF Yield (TTM)

LTRN-135.8%

ZEOX-14.5%

Earnings Yield (TTM)

LTRN-179.9%

ZEOX-41.8%

Dividend Yield (TTM)

LTRNN/A

ZEOXN/A

Rule of 40

LTRN0.0

ZEOX33.4

EV/GP/RG

LTRNN/A

ZEOXN/A

Ticker research

View LTRN research View ZEOX research

Metric	LTRN Lantern Pharma Inc	ZEOX ZEO ScientifiX Inc
Market & Valuation
Market Cap	$10M	$9M
Enterprise Value	$4M	$8M
Price	$0.81	$1.19
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1.33x
EV/Sales	0.00x	1.11x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.19x	16.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.26x	-5.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$7M
Revenue Growth (YoY)	N/A	52.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	81.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-58.0%
Net Margin (TTM)	0.0%	-55.6%
FCF Margin (TTM)	N/A	-19.3%
Net Income (TTM)	$-19M	$-4M
FCF (TTM)	$-14M	$-1M
EPS (TTM)	-$1.50	-$0.50
ROE (TTM)	-19835.0%	0.0%
ROA (TTM)	-18428.0%	-16123.0%
ROIC (TTM)	-19835.0%	0.0%
Financial Health
Cash	$7M	$2M
Debt	$0	$343K
Net Cash/Debt	$7M	$2M
Current Ratio (TTM)	1.96x	1.05x
Quick Ratio (TTM)	1.70x	0.68x
Debt/Equity (TTM)	0.00x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	1.94
52W Performance	-82.3%	-16.5%
YTD Performance	-73.9%	-55.7%
% from 52W High	-82.7%	-60.4%
% from 52W Low	6.9%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	2.90x
FCF Yield (TTM)	-135.8%	-14.5%
Earnings Yield (TTM)	-179.9%	-41.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	33.4
EV/GP/RG	N/A	N/A
Ticker research	View LTRN research	View ZEOX research